Drug Shortage Report for CISPLATIN INJECTION, BP
| Report ID | 225228 |
| Drug Identification Number | 02355183 |
| Brand name | CISPLATIN INJECTION, BP |
| Common or Proper name | CISPLATIN |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CISPLATIN |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 50ML |
| ATC code | L01XA |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2024-06-18 |
| Estimated end date | 2024-10-25 |
| Actual end date | 2024-10-25 |
| Shortage status | Resolved |
| Updated date | 2024-10-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.